Bhagiradha Chemicals and Industries Limited has submitted a Monitoring Agency Report for the quarter ended September 30, 2024, concerning the preferential issue of convertible warrants. The report confirms no deviations from the intended use of proceeds, which amounts to INR 341.18 crore, with INR 288.89 crore utilized to date. This funding supports the establishment of a new manufacturing unit under its subsidiary. The clear allocation of funds and absence of deviations may enhance investor confidence, suggesting a positive outlook for the company's ongoing projects and financial stability.
All announcements from Bhagiradha Chemicals & Industries Limited